Robert E. Ormond

923 total citations
11 papers, 709 citations indexed

About

Robert E. Ormond is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Robert E. Ormond has authored 11 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Organic Chemistry and 3 papers in Molecular Biology. Recurrent topics in Robert E. Ormond's work include Analytical Chemistry and Chromatography (3 papers), Microbial Natural Products and Biosynthesis (3 papers) and Diet and metabolism studies (2 papers). Robert E. Ormond is often cited by papers focused on Analytical Chemistry and Chromatography (3 papers), Microbial Natural Products and Biosynthesis (3 papers) and Diet and metabolism studies (2 papers). Robert E. Ormond collaborates with scholars based in United States. Robert E. Ormond's co-authors include Frederick A. Kuehl, M. A. P. Meisinger, F. A. Kuehl, Theodore A. Jacob, Oswald H. Ganley, G. Albers‐Schönberg, W.J.A. Vandenheuvel, E. O. Stapley, B. G. CHRISTENSEN and A. A. PATCHETT and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

Robert E. Ormond

10 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Ormond United States 10 231 213 138 69 69 11 709
Coy W. Waller United States 15 205 0.9× 278 1.3× 111 0.8× 50 0.7× 152 2.2× 26 632
Bernard A. Koechlin United States 13 202 0.9× 187 0.9× 71 0.5× 266 3.9× 22 0.3× 19 1.1k
Eugene L. Dulaney United States 16 381 1.6× 200 0.9× 116 0.8× 78 1.1× 90 1.3× 54 808
Arthur Stempel Switzerland 19 356 1.5× 252 1.2× 450 3.3× 84 1.2× 71 1.0× 43 974
E. Houghton United Kingdom 28 308 1.3× 133 0.6× 196 1.4× 52 0.8× 22 0.3× 84 1.8k
Paul J. A. Demoen Belgium 10 120 0.5× 65 0.3× 181 1.3× 44 0.6× 16 0.2× 24 593
Benjamin J. Wilson United States 26 336 1.5× 192 0.9× 128 0.9× 28 0.4× 558 8.1× 54 1.5k
B. Yagen Israel 19 235 1.0× 82 0.4× 44 0.3× 66 1.0× 413 6.0× 42 948
YOSUKE SAWADA Japan 20 482 2.1× 425 2.0× 336 2.4× 226 3.3× 163 2.4× 75 1.5k
Yuzo NAKAGAWA Japan 17 506 2.2× 177 0.8× 178 1.3× 192 2.8× 42 0.6× 52 863

Countries citing papers authored by Robert E. Ormond

Since Specialization
Citations

This map shows the geographic impact of Robert E. Ormond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Ormond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Ormond more than expected).

Fields of papers citing papers by Robert E. Ormond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Ormond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Ormond. The network helps show where Robert E. Ormond may publish in the future.

Co-authorship network of co-authors of Robert E. Ormond

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Ormond. A scholar is included among the top collaborators of Robert E. Ormond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Ormond. Robert E. Ormond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Miller, Thomas W., Louis Chaiet, Robert T. Goegelman, et al.. (1979). Avermectins, New Family of Potent Anthelmintic Agents: Isolation and Chromatographic Properties. Antimicrobial Agents and Chemotherapy. 15(3). 368–371. 139 indexed citations
2.
Hume, Robert D., et al.. (1971). Twentieth Century Interpretations of Molloy, Malone Dies, the Unnamable. Journal of Aesthetics and Art Criticism. 29(3). 428–428. 2 indexed citations
3.
Vandenheuvel, W.J.A., et al.. (1970). Characterization of phosphonomycin by microchromatographic and related techniques. Journal of Chromatography A. 52(1). 111–117. 11 indexed citations
4.
CHRISTENSEN, B. G., W. J. Leanza, T. R. BEATTIE, et al.. (1969). Phosphonomycin: Structure and Synthesis. Science. 166(3901). 123–125. 141 indexed citations
5.
Kuehl, Frederick A., W.J.A. Vandenheuvel, & Robert E. Ormond. (1968). Urinary Metabolites in Parkinson's Disease. Nature. 217(5124). 136–138. 23 indexed citations
6.
Kuehl, Frederick A., Robert E. Ormond, & W.J.A. Vandenheuvel. (1966). Occurrence of 3,4-Dimethoxyphenylacetic Acid in Urines of Normal and Schizophrenic Individuals. Nature. 211(5049). 606–608. 31 indexed citations
7.
Wagner, Arthur F., Vincent J. Cirillo, M. A. P. Meisinger, et al.. (1966). A Further Study Of Catecholamine O-Methylation in Schizophrenia. Nature. 211(5049). 604–605. 13 indexed citations
8.
Kuehl, Frederick A., M Hichens, Robert E. Ormond, et al.. (1964). Para-O-Methylation of Dopamine in Schizophrenic and Normal Individuals. Nature. 203(4941). 154–155. 75 indexed citations
9.
Stapley, E. O. & Robert E. Ormond. (1957). Similarity of Albomycin and Grisein. Science. 125(3248). 587–589. 35 indexed citations
10.
Kuehl, F. A., Theodore A. Jacob, Oswald H. Ganley, Robert E. Ormond, & M. A. P. Meisinger. (1957). THE IDENTIFICATION OF N-(2-HYDROXYETHYL)-PALMITAMIDE AS A NATURALLY OCCURRING ANTI-INFLAMMATORY AGENT. Journal of the American Chemical Society. 79(20). 5577–5578. 172 indexed citations
11.
Kuehl, Frederick A., Frank J. Wolf, Nelson R. Trenner, et al.. (1955). D-4-AMINO-3-ISOXAZOLIDONE, A NEW ANTIBIOTIC*. Journal of the American Chemical Society. 77(8). 2344–2345. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026